| Dr Michelle Srisuwananukorn, MD | |
|
9030 Columbia Ave Ste B, Munster, IN 46321-2905 | |
| (219) 836-6002 | |
| Not Available |
| Full Name | Dr Michelle Srisuwananukorn |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 13 Years |
| Location | 9030 Columbia Ave Ste B, Munster, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609160464 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 125059528 (Illinois) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 01078489A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital | Munster, IN | Hospital |
| St Catherine Hospital Inc | East chicago, IN | Hospital |
| St Mary Medical Center Inc | Hobart, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Care Network Inc | 3678737012 | 360 |
News Archive
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution of chemotherapy resistance.
Curemark, a drug research and development company that focuses on the treatment of neurological diseases, has retained Rubenstein Public Relations to help raise national, regional, and industry awareness of the organization's research, treatments and founder, Dr. Joan Fallon. Curemark is developing an autism treatment that will be one of the first to address the underlying physiology of autism.
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.
A weakness in one common open source software for genomic analysis left DNA-based medical diagnostics vulnerable to cyberattacks.
› Verified 4 days ago
| Entity Name | Community Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457610487 PECOS PAC ID: 3678737012 Enrollment ID: O20120614000331 |
News Archive
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution of chemotherapy resistance.
Curemark, a drug research and development company that focuses on the treatment of neurological diseases, has retained Rubenstein Public Relations to help raise national, regional, and industry awareness of the organization's research, treatments and founder, Dr. Joan Fallon. Curemark is developing an autism treatment that will be one of the first to address the underlying physiology of autism.
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.
A weakness in one common open source software for genomic analysis left DNA-based medical diagnostics vulnerable to cyberattacks.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Srisuwananukorn, MD 9030 Columbia Ave, Munster, IN 46321 Ph: (219) 836-6002 | Dr Michelle Srisuwananukorn, MD 9030 Columbia Ave Ste B, Munster, IN 46321-2905 Ph: (219) 836-6002 |
News Archive
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution of chemotherapy resistance.
Curemark, a drug research and development company that focuses on the treatment of neurological diseases, has retained Rubenstein Public Relations to help raise national, regional, and industry awareness of the organization's research, treatments and founder, Dr. Joan Fallon. Curemark is developing an autism treatment that will be one of the first to address the underlying physiology of autism.
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.
A weakness in one common open source software for genomic analysis left DNA-based medical diagnostics vulnerable to cyberattacks.
› Verified 4 days ago
Sahar Halabi, M.D Gastroenterology Medicare: Medicare Enrolled Practice Location: 761 45th St Ste 108, Munster, IN 46321 Phone: 219-922-5416 Fax: 219-922-3745 | |
Wassim Shwaiki, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8840 Calumet Ave Ste 203, Munster, IN 46321 Phone: 219-836-7723 Fax: 219-836-7726 | |
Thottathil Viswanathan Gopan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 761 45th St Ste 110, Munster, IN 46321 Phone: 219-922-3020 Fax: 219-922-3023 | |
Dr. Kyle Kleist, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 701 Superior Ave, Munster, IN 46321 Phone: 219-924-1300 Fax: 219-933-2288 | |
Dr. Gene Lee Chang, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9030 Columbia Ave, Munster, IN 46321 Phone: 219-836-6002 Fax: 219-836-6003 | |
Sana Shoaib Meah, D.O Gastroenterology Medicare: Medicare Enrolled Practice Location: 761 45th Avenue, Suite 110, Munster, IN 46321 Phone: 219-922-3020 Fax: 219-922-3023 | |
Dr. Jay C. L.. Paik, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 800 Macarthur Blvd, #15, Munster, IN 46321 Phone: 219-836-6411 Fax: 219-836-6415 |